Weight Loss Is Evolving: 3 Peptides Changing the Game
Semaglutide, Tirzepatide, and Retatrutide
Losing weight isn’t always as simple as eating less and exercising more. Hunger, hormones, blood sugar, and metabolism all affect how your body manages weight. For many people, these factors can make losing weight difficult, even when they’re eating well and staying active. That’s one reason medical weight loss has changed so much in recent years.
Semaglutide, tirzepatide, and retatrutide are three peptides that work with the body’s natural hormone signals to help manage weight. They share some similarities, but each targets different pathways involved in hunger, blood sugar, and metabolism. Understanding how they work can help you see why these medications have become such an important part of the weight loss conversation.
Semaglutide: Helping You Feel Full and Eat Less
Semaglutide works by copying the action of GLP-1, a hormone your body naturally releases after eating. GLP-1 helps reduce hunger, slows how quickly food leaves your stomach, and helps control blood sugar. One of the biggest changes patients often notice is less “food noise.” This is the constant thinking about food, cravings, or feeling hungry even after eating. When those signals become quieter, making healthier choices can feel easier. Semaglutide also helps you feel satisfied with smaller portions, so you’re not relying entirely on willpower to manage how much you eat.
Research has shown how effective this approach can be. In the STEP 1 clinical study, adults taking semaglutide lost an average of approximately 15% of their starting body weight over 68 weeks, compared with 2.4% in the placebo group. For someone weighing 220 pounds, that’s about 33 pounds. Results vary from person to person, but these findings show how much our natural appetite hormones can influence weight loss.
Tirzepatide: Why Adding GIP Matters
Tirzepatide builds on the GLP-1 approach by targeting two hormone pathways instead of one: GLP-1 and GIP. We already know that GLP-1 helps reduce hunger and increases feelings of fullness. GIP is another hormone released after eating that helps your body release insulin when blood sugar rises. It also affects how the brain responds to hunger signals and how the body handles nutrients. Adding GIP may strengthen the appetite-reducing effects of GLP-1, helping explain why tirzepatide can produce greater weight loss than semaglutide. The exact way these two hormones work together is still being studied.
In the SURMOUNT-5 study, researchers directly compared tirzepatide and semaglutide in adults with obesity who did not have diabetes. After 72 weeks, patients taking tirzepatide lost an average of 20.2% of their body weight, compared with 13.7% for those taking semaglutide. These findings show the potential benefit of targeting both hormone pathways, although individual results vary. Choosing a medication still depends on your medical history, how well you tolerate treatment, and your personal health goals.
Retatrutide: Why Adding Glucagon Matters
Retatrutide targets three hormone pathways: GLP-1, GIP, and glucagon. While GLP-1 and GIP help manage hunger and blood sugar, glucagon adds another effect. It helps the body manage stored energy and may increase the number of calories the body burns. This means retatrutide may work in two important ways: helping people eat less while also increasing how much energy the body uses. Researchers believe this added pathway may contribute to the significant weight loss seen in early studies.
In a phase 2 clinical study, participants receiving the highest tested dose lost an average of approximately 24.2% of their body weight after 48 weeks. Another study found large reductions in liver fat among people with metabolic dysfunction-associated steatotic liver disease (MASLD), a condition in which too much fat builds up in the liver. These findings are promising because they suggest retatrutide may offer benefits beyond weight loss. However, retatrutide remains an investigational medication, and researchers are still studying its long-term safety and effectiveness.
Preserving Muscle During Weight Loss
One of the most important parts of medical weight loss is protecting muscle. When someone loses a significant amount of weight, some of that loss can come from muscle rather than body fat. This matters because muscle helps maintain strength, supports blood sugar control, and keeps us active as we age. Preserving muscle becomes especially important for men and women experiencing hormonal changes as they get older.
Eating enough protein, doing resistance exercises, and staying physically active can help protect muscle during weight loss. Because these medications reduce hunger, some patients may eat too little without realizing it, making it harder to get the protein and nutrients their bodies need. This is why nutrition and regular medical follow-up are important parts of treatment. The goal isn’t simply to lose pounds. It’s to reduce excess body fat while maintaining strength, energy, and overall health.
What About Side Effects?
Semaglutide and tirzepatide commonly cause digestive side effects, including nausea, constipation, diarrhea, vomiting, and feeling overly full. Similar effects have been reported in retatrutide studies. These symptoms are often more noticeable when starting treatment or increasing a dose, and many improve as the body adjusts. However, some people experience more serious problems that require medical attention.
Before starting treatment, it’s important to review your medical history, current medications, and any conditions that could make these medications unsafe. Gradual dose adjustments, staying hydrated, eating enough, and having regular follow-ups can help manage common side effects. The goal is to find an effective treatment that your body tolerates well, rather than increasing the dose simply to lose weight faster.
The Bottom Line
Medical weight loss has come a long way, giving us new ways to help people manage their weight and improve their health. Semaglutide, tirzepatide, and retatrutide show how understanding the body’s natural hormones can lead to new treatment approaches. While the research is encouraging, no single medication is the right choice for everyone, and results from separate studies shouldn’t be treated as a direct comparison.
Medication is also only one part of successful weight management. Protecting muscle, eating well, staying active, and choosing a treatment that fits your health needs are just as important as the number on the scale. At Axios Health & Wellness, our goal is to help patients achieve lasting results while improving their overall health.
Ready to Take the Next Step?
If you’re struggling with weight loss or want to better understand your options, Axios Health & Wellness offers personalized medical weight loss programs based on your individual needs. We’ll review your health history, discuss appropriate treatment options, and help you develop a plan focused on lasting results.
Schedule your consultation today and take the next step toward better health.
Axios Health & Wellness
700 Ken Pratt Blvd., Suite 108
Longmont, CO 80501
Phone: 720-899-9400
Website: www.axioshealthco.com
About the Author
This article was written by Jay Griffin, FNP-C, CRNFA.
Jay is a board-certified Family Nurse Practitioner, hormone optimization specialist, and founder of Axios Health & Wellness. With more than 25 years of healthcare experience, he specializes in hormone replacement therapy, thyroid optimization, peptide therapy, medical weight loss, and regenerative medicine.
His goal is to help patients better understand the science behind their health and make informed decisions through evidence-based, personalized care.
Jay Griffin, FNP-C, CRNFA
Board-Certified Family Nurse Practitioner
Hormone Optimization Specialist
Founder, Axios Health & Wellness
Frequently Asked Questions
1. What is the difference between semaglutide and tirzepatide?
Semaglutide targets GLP-1 receptors, while tirzepatide targets both GLP-1 and GIP receptors. Both help regulate appetite and blood sugar, but tirzepatide has produced greater average weight loss in direct comparative research.
2. Is retatrutide stronger than tirzepatide?
Retatrutide has demonstrated substantial weight loss in clinical studies, but separate trial results cannot establish that it is more effective than tirzepatide. Direct comparative evidence is needed.
3. Can these medications help with insulin resistance?
Yes. Semaglutide and tirzepatide improve glucose regulation, and retatrutide has also demonstrated improvements in glycemic measures during clinical research.
4. Will I lose muscle while taking weight loss medications?
Some lean tissue loss can accompany significant weight reduction. Adequate protein, resistance training, and appropriate medical monitoring help support muscle preservation.
5. Do I need to stay on weight loss medication forever?
Treatment duration varies. Obesity is often a chronic condition, and weight regain can occur after stopping effective medication. Maintenance decisions should consider metabolic health, treatment response, and individual goals.
References
- Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine. 2021;384:989–1002.
Aronne LJ, Horn DB, le Roux CW, et al. Tirzepatide as compared with semaglutide for the treatment of obesity. New England Journal of Medicine. 2025.
Jastreboff AM, Kaplan LM, Frías JP, et al. Triple-hormone-receptor agonist retatrutide for obesity: A phase 2 trial. New England Journal of Medicine. 2023;389:514–526.
Sanyal AJ, Kaplan LM, Frias JP, et al. Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: A randomized phase 2a trial. Nature Medicine. 2024;30:2037–2048.